ArticleArchivum immunologiae et therapiae experimentalis2014

Antitumor effects of recombinant antivascular protein ABRaA-VEGF121 combined with IL-12 gene therapy.

Agnieszka Ciomber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.